Outcomes Following Surgical Repair of Sinus Venosus Atrial Septal Defects: A Systematic Review and Meta‐Analysis
Open Access
- 18 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (12) , e033686
Abstract
Background: Sinus venosus atrial septal defect (SVASD) is a rare congenital cardiac anomaly comprising 5% to 10% of all atrial septal defects. Although surgical closure is the standard treatment for SVASD, data on outcomes have been confined to small cohorts. Thus, we conducted a systematic review of the outcomes of SVASD repair. Methods and Results: The primary outcome was death. Secondary outcomes encompassed atrial fibrillation, sinus node dysfunction, pacemaker insertion, cerebrovascular accident, reoperation, residual septal defect, superior vena cava obstruction, and reimplanted pulmonary vein obstruction. Pooled incidences of outcomes were calculated using a random‐effects model. Forty studies involving 1320 patients who underwent SVASD repair were included. The majority were male patients (55.4%), with 88.0% presenting with associated anomalous pulmonary venous connection. The weighted mean age was 18.6±12.5 years, and the overall weighted mean follow‐up period was 8.6±10.4 years. The in‐hospital mortality rate was 0.24%, with a 30‐day mortality rate of 0.5% reported in 780 patients. Incidences of atrial fibrillation, sinus node dysfunction, pacemaker insertion, and cerebrovascular accident over the long‐term follow‐up were 3.3% (2.18%–4.93%), 6.5% (5.09%–8.2%), 2.23% (1.34%–3.57%), and 2.03% (0.89%–2.46%) respectively. Reoperation occurred in 1.36% (0.68%–2.42%) of surgeries, residual septal defect in 1.34% (0.69%–2.42%), superior vena cava obstruction in 1.76% (1.02%–2.9%), and reimplanted pulmonary vein obstruction in 1.4% (0.7%–2.49%). Conclusions: This is the first comprehensive analysis of outcomes following surgical repair of SVASD. The findings affirm the safety and effectiveness of surgery, establishing a reference point for evaluating emerging transcatheter therapies. Safety and efficacy profiles comparable to surgical repair are essential for widespread adoption of transcatheter treatments.Keywords
This publication has 59 references indexed in Scilit:
- Sinus node dysfunction during transcatheter assessment and stent correction of sinus venosus atrial septal defectsCatheterization and Cardiovascular Interventions, 2023
- Simultaneous Transcatheter Closure of Coexistent Superior Sinus Venosus Defects and Oval Fossa DefectsPediatric Cardiology, 2023
- Transcatheter versus surgical treatment for isolated superior sinus venosus atrial septal defectCatheterization and Cardiovascular Interventions, 2023
- A new FDA approved stent for congenital heart disease: First‐in‐man experiences with G‐ARMORTMCatheterization and Cardiovascular Interventions, 2022
- Novel technique for transcatheter closure of sinus venosus atrial septal defect: The temporary suture‐holding techniqueCatheterization and Cardiovascular Interventions, 2022
- Exact inference for fixed‐effects meta‐analysis of proportionsResearch Synthesis Methods, 2021
- Transcatheter closure of sinus venosus atrial septal defect with anomalous pulmonary venous drainage: Innovative technique with long‐term follow‐upCatheterization and Cardiovascular Interventions, 2019
- The wedding cake solution: A percutaneous correction of a form fruste superior sinus venosus atrial septal defectCatheterization and Cardiovascular Interventions, 2015
- Prevalence of Treatment, Risk Factors, and Management of Atrial Septal Defects in a Pediatric Medicaid CohortPediatric Cardiology, 2013
- Surgical techniques in partial anomalous pulmonary veins to the superior vena cavaThe Annals of Thoracic Surgery, 1993